Literature DB >> 12565872

Cloning and characterization of a functional promoter of the human SOCS-3 gene.

Biao He1, Liang You, Kazutsugu Uematsu, Maria Matsangou, Zhidong Xu, Miao He, Frank McCormick, David M Jablons.   

Abstract

SOCS-3 is a member of a newly discovered protein family that inhibits LIF-activated Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in a negative auto-regulatory manner. In this study, we have cloned and characterized the promoter region of the human SOCS-3 gene. This region is approximately 1.1 kbp in length and consists of two putative STAT-binding elements, a G-rich element, and a putative TATA box. These elements are highly conserved in both murine and rat SOCS-3 promoters. Functional analysis of this region shows that the whole fragment (approximately 1.1 kbp) has high basal promoter activity and is responsive to growth factors. We also found that the wild type SOCS-3 promoter construct has significantly greater activity in non-small-cell lung cancer cell lines than in normal cells in accordance with STAT3 disregulation in these cells. Cloning of the human SOCS-3 promoter should help uncover mechanisms of regulation of the JAK-STAT pathway in human cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12565872     DOI: 10.1016/s0006-291x(02)03071-1

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

Review 1.  Regulation of the inflammatory response of vascular endothelial cells by EPAC1.

Authors:  Euan Parnell; Brian O Smith; Timothy M Palmer; Anna Terrin; Manuela Zaccolo; Stephen J Yarwood
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Methylation and microRNA-mediated epigenetic regulation of SOCS3.

Authors:  Chandra S Boosani; Devendra K Agrawal
Journal:  Mol Biol Rep       Date:  2015-04       Impact factor: 2.316

3.  Exchange protein activated by cyclic AMP (Epac)-mediated induction of suppressor of cytokine signaling 3 (SOCS-3) in vascular endothelial cells.

Authors:  William A Sands; Hayley D Woolson; Gillian R Milne; Claire Rutherford; Timothy M Palmer
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

4.  Both STAT3 activation and cholesterol efflux contribute to the anti-inflammatory effect of apoA-I/ABCA1 interaction in macrophages.

Authors:  Chongren Tang; Barbara A Houston; Carl Storey; Renee C LeBoeuf
Journal:  J Lipid Res       Date:  2016-03-17       Impact factor: 5.922

5.  Suppressor of cytokine signaling 3 inhibits breast tumor kinase activation of STAT3.

Authors:  Yiwei Gao; Velasco Cimica; Nancy C Reich
Journal:  J Biol Chem       Date:  2012-04-30       Impact factor: 5.157

6.  STAT1, STAT6 and adenosine 3',5'-cyclic monophosphate (cAMP) signaling drive SOCS3 expression in inactive ulcerative colitis.

Authors:  Yi Li; Jasper Deuring; Maikel P Peppelenbosch; Ernst J Kuipers; Colin de Haar; C Janneke van der Woude
Journal:  Mol Med       Date:  2012-12-20       Impact factor: 6.354

7.  The STAT3 NH2-terminal domain stabilizes enhanceosome assembly by interacting with the p300 bromodomain.

Authors:  Tieying Hou; Sutapa Ray; Chang Lee; Allan R Brasier
Journal:  J Biol Chem       Date:  2008-09-09       Impact factor: 5.157

8.  SOCS3 promotor hypermethylation and STAT3-NF-κB interaction downregulate SOCS3 expression in human coronary artery smooth muscle cells.

Authors:  Kajari Dhar; Kriti Rakesh; Divya Pankajakshan; Devendra K Agrawal
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-01-18       Impact factor: 4.733

9.  Acute alcohol intake induces SOCS1 and SOCS3 and inhibits cytokine-induced STAT1 and STAT3 signaling in human monocytes.

Authors:  Oxana Norkina; Angela Dolganiuc; Donna Catalano; Karen Kodys; Pranoti Mandrekar; Amber Syed; Marian Efros; Gyongyi Szabo
Journal:  Alcohol Clin Exp Res       Date:  2008-07-09       Impact factor: 3.455

10.  Regulation of multiple cytokine signalling pathways by SOCS3 is independent of SOCS2.

Authors:  Hiu Kiu; Christopher J Greenhalgh; Anne Thaus; Douglas J Hilton; Nicos A Nicola; Warren S Alexander; Andrew W Roberts
Journal:  Growth Factors       Date:  2009-12       Impact factor: 2.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.